Lee Wachtel, MD, Medical Director, Neurobehavioral Unit, Kennedy Krieger Institute. Psychiatry Professor, Johns Hopkins School of Medicine. Baltimore, MD.
Dr. Wachtel, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Dax Volle, MD. Dr. Volle, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report.
Uma Naidoo, MD. Director of Nutritional and Metabolic Psychiatry, Massachusetts General Hospital (MGH); Director of Nutritional & Lifestyle Psychiatry, MGH Academy; Author, This Is Your Brain on Food (Little, Brown Spark; 2020).
The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Fredrik Jarskog, MD. Associate Professor of Clinical Psychiatry, Chief of Clinical Therapeutics Lieber Center for Schizophrenia Research and Treatment New York State Psychiatric Institute/Columbia University.
Dr. Jarskog has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity. Dr. Jarskog has disclosed that glycine, D-serine, D-cycloserine, and Glu2/3 receptor agonists are not FDA-approved for the treatment of schizophrenia.
PO Box 626, Newburyport MA 01950